Cargando…

Plasma hsa‐mir‐19b is a potential LevoDopa therapy marker

Parkinson's disease (PD) is the second most common neurodegenerative disorder among the elderly, the diagnostic and prognostic of which is based mostly on clinical signs. LevoDopa replacement is the gold standard therapy for PD, as it ameliorates the motor symptoms. However, it does not affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chis, Aimee Rodica, Moatar, Alexandra Ioana, Dijmarescu, Cristina, Rosca, Cecilia, Vorovenci, Ruxandra Julia, Krabbendam, Inge, Dolga, Amalia, Bejinar, Cristina, Marian, Catalin, Sirbu, Ioan Ovidiu, Simu, Mihaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435426/ https://www.ncbi.nlm.nih.gov/pubmed/34328686 http://dx.doi.org/10.1111/jcmm.16827

Ejemplares similares

Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease
por: Moatar, Alexandra Ioana, et al.
Publicado: (2022)

Plasma hsa-miR-22-3p Might Serve as an Early Predictor of Ventricular Function Recovery after ST-Elevation Acute Myocardial Infarction
por: Maries, Liana, et al.
Publicado: (2023)

Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients
por: Moatar, Alexandra Ioana, et al.
Publicado: (2023)

Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction
por: Maries, Liana, et al.
Publicado: (2023)

Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
por: Athulya, RT, et al.
Publicado: (2020)

MicroRNAs mediate liver transcriptome changes upon soy diet intervention in mice
por: Seclaman, Edward, et al.
Publicado: (2019)

Electroanalytical Overview: The Determination of Levodopa (L-DOPA)
por: Crapnell, Robert D., et al.
Publicado: (2023)

Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing
por: Capraru, Ionut Dragos, et al.
Publicado: (2022)

Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study
por: Vizitiu, Anda-Cornelia, et al.
Publicado: (2019)

Uncovering New Drug Properties in Target-Based Drug–Drug Similarity Networks
por: Udrescu, Lucreţia, et al.
Publicado: (2020)

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson’s disease: systematic review, meta-analysis, and economic evaluation
por: Yi, Zhan-Miao, et al.
Publicado: (2018)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease
por: Li, Lanting, et al.
Publicado: (2020)

P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content
por: Soumyanath, A, et al.
Publicado: (2012)

A Case of GCH-1 Mutation Dopa-Responsive Dystonia Requiring High Doses of Levodopa for Treatment
por: Bradley, Maeve, et al.
Publicado: (2021)

Case Report: Clinical Outcome From Pallidal Stimulation in a Patient With Levodopa-Resistant Dopa-Responsive Dystonia
por: Wang, Xue, et al.
Publicado: (2022)

Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice
por: Guo, Zhenggang, et al.
Publicado: (2014)

Spontaneous Coronary Artery Dissection in Levo-Transposition of the Great Arteries
por: Sharma, Avinash V., et al.
Publicado: (2019)

Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients
por: Landi, Claudia, et al.
Publicado: (2022)

Preparation of the Levo-Tetrahydropalmatine Liposome Gel and Its Transdermal Study
por: Zhang, Guizhen, et al.
Publicado: (2023)

The absorption of liquid levo-thyroxine is not significantly impaired by food intake
por: De Luca, Filippo
Publicado: (2016)

Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
por: Takada, Ryoji, et al.
Publicado: (2023)

Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
por: Simu, Mihaela Adriana, et al.
Publicado: (2021)

Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor
por: Szczesna, Karolina, et al.
Publicado: (2014)

Designing Silver Nanoparticles for Detecting Levodopa (3,4-Dihydroxyphenylalanine, L-Dopa) Using Surface-Enhanced Raman Scattering (SERS)
por: Rubira, Rafael Jesus Gonçalves, et al.
Publicado: (2019)

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients
por: Constantin, Viorelia Adelina, et al.
Publicado: (2020)

Levo-Tetrahydropalmatine Attenuates Bone Cancer Pain by Inhibiting Microglial Cells Activation
por: Zhang, Mao-yin, et al.
Publicado: (2015)

Levo-transposition of the Great Arteries in an Adult Patient: Management Considerations and Treatment Strategy
por: Lozier, Matthew R, et al.
Publicado: (2019)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement in a Patient With Levo-Transposition of the Great Arteries
por: Kellett, Eric, et al.
Publicado: (2020)

Leadless ventricular pacemaker implant with atrial sensing in levo-transposition of the great arteries
por: Rutland, Joshua, et al.
Publicado: (2021)

The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Gadalean, Florica, et al.
Publicado: (2017)

MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling
por: Maries, Liana, et al.
Publicado: (2021)

Acute Pulmonary Edema in a Pregnant Patient with Undiagnosed Levo-Transposition of the Great Arteries
por: Karamchandani, Kunal, et al.
Publicado: (2018)

Effects of Aging on Levo-Dihydroxyphenylalanine- Induced Dyskinesia in a Rat Model of Parkinson’s Disease
por: Nishijima, Haruo, et al.
Publicado: (2021)

L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
por: Stocchi, Fabrizio, et al.
Publicado: (2015)

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats
por: Wang, Wen-Wen, et al.
Publicado: (2019)

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
por: Dobarro, David, et al.
Publicado: (2023)

L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017)

Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
por: Fasano, Alfonso, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ccgd5r3437ds5hul7iq59gsta